Tag: SOTIO

biotech

Orphan Drug Designation for potential best-in-class ADC for sarcoma

biotech

FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment

biotech

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

biotech

Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments

biotech

Fast Track Designation for Lynch syndrome-associated cancers treatment